Recognition and management of extended spectrum beta lactamase producing organisms (ESBL)
Fircanis, S.; McKay, M.
Medicine and Health Rhode Island 93(5): 161-162
2010
ISSN/ISBN: 1086-5462 PMID: 20533728 Document Number: 643430
ESBL organisms provide a continuing challenge in the geriatric community. They are increasingly prevalent, and pose unique challenges in treatment. Carbapenems are the mainstay of therapy; however they are expensive medications that require prolonged intravenous administration. Carbapenem resistance is a growing concern among frequently hospitalized patients and nursing home residents, and options for treatment of MDROs are limited. Attempts at minimizing the spread of beta-lactamase producers through hygiene and contact precautions are imperative, as is ongoing research into more effective antimicrobial agents.
Document emailed within 1 workday
Related Documents
Nurul Atifah, M.A.; Loo, H.K.C.; Subramaniam, G.; Wong, E.H.; Selvi, P.; Ho, S.E.; Kamarulzaman, A.; Parasakthi, N. 2005: Faecal prevalence of extended-spectrum Beta-lactamase (ESBL)-producing coliforms in a geriatric population and among haematology patients Malaysian Journal of Pathology 27(2): 75-81Tribuddharat, C.; Srifuengfung, S.; Chiangjong, W. 2008: Preliminary study of randomly-amplified polymorphic DNA analysis for typing extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae Journal of the Medical Association of Thailand 91(4): 527-532
Bayraktar, B.; Toksoy, B.; Bulut, E. 2010: Detection of bla(CTX-M) beta-lactamase genes in extended-spectrum beta-lactamase producing gram-negative bacteria Mikrobiyoloji Bulteni 44(2): 187-196
Silva-Sánchez, J.; Aguilar-Zacarías, C. 1997: Beta-Lactamase bioassay: a simplified method to determine extended-spectrum beta-lactamases (ESBL) in enterobacteria Archives of Medical Research 28(2): 285-287
Sinha, M.; Srinivasa, H.; Macaden, R. 2007: Antibiotic resistance profile and extended spectrum beta-lactamase (ESBL) production in Acinetobacter species Indian Journal of Medical Research 126(1): 63-67
González Mesa, L.; Ramos Morí, A.; Nadal Becerra, L.; Morffi Figueroa, J.; Hernández Robledo, E.; Alvarez, A.B.; Marchena Bequer, J.J.; González Alemán, M.; Villain Plous, C. 2007: Phenotypic and molecular identification of extended-spectrum beta-lactamase (ESBL) TEM and SHV produced by clinical isolates Escherichia coli and Klebsiella spp. in hospitals Revista Cubana de Medicina Tropical 59(1): 52-58
Kuga, A.; Yano, H.; Okamoto, R.; Sato, Y.; Miyata, A.; Inoue, M. 1999: Antibacterial activity of beta-lactam antibiotics against extended-spectrum beta-lactamase producing bacteria Japanese Journal of Antibiotics 52(9): 585-594
Tuchiluş, C.; Poiată, A.; Bosnea, D.; Bădicuţ, I.; Buiuc, D. 2002: Resistance pattern of extended-spectrum beta-lactamase producing Enterobacteriaceae isolates Roumanian Archives of Microbiology and Immunology 61(4): 285-291
Lautenbach, E.; Fishman, N.O. 1999: Control of outbreaks due to organisms producing extended-spectrum beta-lactamases JAMA 281(12): 1080-1081
Wang, L.; Yang, Y.-h.; Lu, Q.; Wang, Y.; Chen, Y.; Deng, L.; Deng, Q.-l.; Zhang, H.; Wang, C.-q.; Liu, L.; Xu, X.-w.; Shen, X.-z. 2008: Prevalence of extended-spectrum beta-lactamase producing Escherichia coli in pediatric patients in China Zhonghua Yi Xue Za Zhi 88(20): 1372-1375
Wang, Q.-t.; Liu, Y.-m.; Wang, H.; Sun, H.-l.; Chen, M.-j.; Du, X.-l. 2004: Plasmid-mediated cephalosporinase among extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae Zhonghua Nei Ke Za Zhi 43(7): 487-490
Yip, T.; Tse, K.-C.; Lam, M.-F.; Tang, S.; Li, F.-K.; Choy, B.-Y.; Lui, S.-L.; Chan, T.-M.; Lai, K.-N.; Lo, W.-K. 2006: Risk factors and outcomes of extended-spectrum beta-lactamase-producing E. coli peritonitis in CAPD patients Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 26(2): 191-197
Suankratay, C.; Jutivorakool, K.; Jirajariyavej, S. 2008: A prospective study of ceftriaxone treatment in acute pyelonephritis caused by extended-spectrum beta-lactamase-producing bacteria Journal of the Medical Association of Thailand 91(8): 1172-1181
Silago, V.; Mukama, Y.; Haule, A.L.; Chacha, F.; Igenge, J.; Mushi, M.F.; Mshana, S.E. 2020: Bacteriospermia, extended spectrum beta lactamase producing Gram-negative bacteria and other factors associated with male infertility in Mwanza, Tanzania: a need of diagnostic bacteriology for management of male infertility African Health Sciences 20(1): 4-13
Maurya, A.Prakash.; Choudhury, D.; Talukdar, A.Das.; Dhar Chanda, A.; Chakravarty, A.; Bhattacharjee, A. 2014: A report on the presence of GES-5 extended spectrum beta-lactamase producing Pseudomonas aeruginosa associated with urinary tract infection from north-east India Indian Journal of Medical Research 140(4): 565-567
Zhang, W.-l.; Liu, J.; Zhang, J.; Su, G.-l. 2011: Analysis of antibiotic resistance and genotypes on extended spectrum β-lactamase and AmpC β-lactamase producing strains isolated from Uygur and Han newborns Zhonghua Yu Fang Yi Xue Za Zhi 45(3): 217-224
Baykal, A.; Cöplü, N.; Simşek, H.üs.; Esen, B.; Gür, D. 2012: The presence of extended spectrum beta-lactamase, KPC-type carbapenemase and plasmid-mediated AmpC beta-lactamase in E.coli and K.pneumoniae strains isolated from blood cultures Mikrobiyoloji Bulteni 46(2): 159-169
Pessoa-Silva, C.Lúcia.; Toscano, C.M.; Moreira, B.Meurer.; Santos, A.Lúcia.; Frota, A.Cristina.Cisne.; Solari, C.Andre.; Amorim, Eênia.L.t.; Carvalho, M.Da.Gloria.S.; Teixeira, Lúcia.Martins.; Jarvis, W.R. 2002: Infection due to extended-spectrum beta-lactamase-producing Salmonella enterica subsp. enterica serotype infantis in a neonatal unit Journal of Pediatrics 141(3): 381-387
Moodley, P.; Coovadia, Y.M.; Sturm, A.Willem. 2005: Intravenous glucose preparation as the source of an outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae infections in the neonatal unit of a regional hospital in KwaZulu-Natal South African Medical Journal 95(11): 861-864
Jacobs, M.R.; Aronoff, S.C.; Johenning, S.; Shlaes, D.M.; Yamabe, S. 1986: Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli Antimicrobial Agents and Chemotherapy 29(6): 980-985